| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5722506 | Psiquiatría Biológica | 2017 | 8 Pages |
Abstract
Omega-3 fatty acids may currently appear as an adjuvant agent for the treatment of depression, with this recommendation being endorsed by several meta-analyses that involve a high level of evidence, which has led to their use being contemplated in clinical guidelines or recommendations by experts. Some meta-analyses found superiority of eicosapentaenoic acid (EPA) over docosahexaenoic acid (DHA), and recommend a higher proportion of the former if omega-3 fatty acids are chosen as adjuvants agents in antidepressant treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Javier Caballer GarcÃa, Esther TorÃo Ojea, LuÃs Jimenez Treviño, Secundino Sánchez Fernández,